Abstract
The course of chronic hepatitis C in acute HDV/HBV superinfection is unknown. Here, we report a patient with chronic hepatitis C who cleared HCV during acute self-limited hepatitis B/D superinfection. Recovery from HCV was associated with the appearance of a strong and multispecific HDV-specific memory CD4+ and CD8+ T cell response – but only weak HCV-specific CD4+ T cell responses. These data suggest that HCV can be cleared by bystander mechanisms during acute infections with other pathogens which may be considered in the development of immunotherapies for hepatitis C.
Similar content being viewed by others
References
Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001; 34:404–410.
Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 2000; 32:1106–1110.
Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM: Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004; 126:1024–1029.
Liaw YF: Concurrent hepatitis B and C virus infection: Is hepatitis C virus stronger? J Gastroenterol Hepatol 2001; 16:597–598.
Mathurin P, Thibault V, Kadidja K, Ganne-Carrie N, Moussalli J, ElYounsi M, et al. Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections. J Viral Hepat 2000; 7:15–22.
Gruener NH, Jung MC, Ulsenheimer A, Gerlach TJ, Diepolder HM, Schirren CA, et al. Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response. J Hepatol 2002; 37:866–869.
Wietzke P, Schott P, Braun F, Mihm S, Ramadori G: Clearance of HCV RNA in a chronic hepatitis C virus-infected patient during acute hepatitis B virus superinfection. Liver 1999; 19:348–353.
Deterding K, Tegtmeyer B, Cornberg M, Hadem J, Potthoff A, Boker KH, et al. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV. J Hepatol 2006; 45:770–778.
Sagnelli E, Coppola N, Pisaturo M, Pisapia R, Onofrio M, Sagnelli C, et al. Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection. Clin Infect Dis 2006; 42:1536–1543.
Tillmann HL, Hadem J, Leifeld L, Zachou K, Canbay A, Eisenbach C, et al. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 2006; 13:256–263.
Wiegand J, Aslan N, Ciner A, Buggisch P, Jaeckel E, Cornberg M, et al. Kinetics of HCV-specific CD4+ and CD8+ T cell responses during and after therapy with pegylated interferon-alfa-2B in patients with acute hepatitis C. Hepatology 2004; 40:256A.
Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002; 169:3447–3458.
Devalle S, de Paula VS, de Oliveira JM, Niel C, Gaspar AM: Hepatitis A virus infection in hepatitis C Brazilian patients. J Infect 2003; 47:125–128.
Schuttler CG, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S: Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 2002; 37:855–862.
Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH: Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993; 67:5823–5832.
Guidotti LG, Chisari FV: Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19:65–91.
Lauer GM, Lucas M, Timm J, Ouchi K, Kim AY, Day CL, et al. Fullbreadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy. J Virol 2005; 79:12979–12988.
Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV: Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194:1395–1406.
Guo JT, Bichko VV, Seeger C: Effect of alpha interferon on the hepatitis C virus replicon. J Virol 2001; 75:8516–8523.
Frese M, Pietschmann T, Moradpour D, Haller O, Bartenschlager R: Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 2001; 82:723–733.
Guidotti LG, Borrow P, Hobbs MV, Matzke B, Gresser I, Oldstone MB, et al. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci USA 1996; 93:4589–4594.
Cavanaugh VJ, Guidotti LG, Chisari FV: Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol 1998; 72:2630–2637.
Pasquetto V, Guidotti LG, Kakimi K, Tsuji M, Chisari FV: Hostvirus interactions during malaria infection in hepatitis B virus transgenic mice. J Exp Med 2000; 192:529–536.
McClary H, Koch R, Chisari FV, Guidotti LG: Inhibition of hepatitis B virus replication during schistosoma mansoni infection in transgenic mice. J Exp Med 2000; 192:289–294.
Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology 2007; 45:507–539.
Author information
Authors and Affiliations
Corresponding author
Additional information
*KD and SVP contributed equally.
Rights and permissions
About this article
Cite this article
Deterding, K., Pothakamuri, S.V., Schlaphoff, V. et al. Clearance of Chronic HCV Infection During Acute Delta Hepatitis. Infection 37, 159–162 (2009). https://doi.org/10.1007/s15010-007-7204-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-007-7204-7